Survey on patient preferences for myeloma treatment - Myeloma
Descrição
Dutch (Nederlands) Voorkeuren van patiënten omtrent behandelingen voor myeloom Finnish (suomi) Potilaan mieltymykset myelooman hoidoista French (français) Préférences des patients concernant les traitements du myélome German (Deutsch) Patientenpräferenzen zu Myelombehandlungen Romanian (Română) Preferințele pacientului cu privire la tratamentele pentru mielom Spanish (Español) Preferencias del paciente sobre los tratamientos del mieloma Our work is driven by the needs of myeloma patients. To best represent the patient voice in policy decisions, we need to…
Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline
Patient preferences regarding treatment options for Waldenström's macroglobulinemia: A discrete choice experiment - Amaador - 2023 - Cancer Medicine - Wiley Online Library
Once weekly versus twice weekly carfilzomib dosing in patients with relapsed and refractory multiple myeloma (A.R.R.O.W.): interim analysis results of a randomised, phase 3 study - The Lancet Oncology
Approach to the Older Adult With Multiple Myeloma American Society of Clinical Oncology Educational Book
Patient preferences regarding treatment options for Waldenström's macroglobulinemia: A discrete choice experiment - Amaador - 2023 - Cancer Medicine - Wiley Online Library
Overcoming Barriers to Autologous Stem Cell Transplantation in Multiple Myeloma: Recommendations from a Multidisciplinary Roundtable Discussion - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and
Multiple Myeloma Hub on X: Clinician preferences on the treatment of smoldering multiple myeloma, check out our key points below! 🎙️ What treatment would you recommend for smoldering #multiplemyeloma? HCPs, share your
When and How to Treat Relapsed Multiple Myeloma American Society of Clinical Oncology Educational Book
Alignment of preferences in the treatment of multiple myeloma – a discrete choice experiment of patient, carer, physician, and nurse preferences, BMC Cancer
Physician treatment preferences for relapsed/refractory multiple myeloma: a discrete choice experiment
Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial - The Lancet Oncology
Current Oncology, Free Full-Text
PDF) Physician treatment preferences for relapsed/refractory multiple myeloma: a discrete choice experiment
de
por adulto (o preço varia de acordo com o tamanho do grupo)
